NASDAQ:SYNO - Synovis Life Technologies Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
Previous CloseN/A
Today's RangeN/A
52-Week RangeN/A
VolumeN/A
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Synovis Life Technologies, Inc. (Synovis) is a medical device company. The Company develops, manufactures and markets biological and mechanical products used by several surgical specialties to facilitate the repair and reconstruction of soft tissue damaged or destroyed by disease or injury. Its products include implantable biomaterials for soft tissue repair, devices for microsurgery and surgical tools. The Company operates in three segments: the surgical business, the microsurgical business, and the Ortho & Wound business. Its surgical business develops, manufactures, markets, and sells implantable biomaterial products and surgical tools. Its surgical business products include Peri-Strips, Tissue Guard, Veritas, and Surgical Tools. The Company's microsurgical business develops, manufactures, markets, and sells devices serving the niche market of microsurgery. In February 2012, Baxter International Inc. acquired Synovis.

Receive SYNO News and Ratings via Email

Sign-up to receive the latest news and ratings for SYNO and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NASDAQ
Industry N/A
Sub-IndustryN/A
SectorN/A
Current SymbolNASDAQ:SYNO
Previous Symbol
CUSIPN/A
WebN/A
Phone+1-651-7967300

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / Cash FlowN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

EmployeesN/A
Outstanding SharesN/A
Market Cap$0.00
OptionableNot Optionable

Synovis Life Technologies (NASDAQ:SYNO) Frequently Asked Questions

What is Synovis Life Technologies' stock symbol?

Synovis Life Technologies trades on the NASDAQ under the ticker symbol "SYNO."

Has Synovis Life Technologies been receiving favorable news coverage?

Press coverage about SYNO stock has trended somewhat positive recently, according to InfoTrie. The research group ranks the sentiment of press coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Synovis Life Technologies earned a coverage optimism score of 0.8 on InfoTrie's scale. They also gave news coverage about the medical device company a news buzz of 1.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the stock's share price in the next several days.

How do I buy shares of Synovis Life Technologies?

Shares of SYNO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How can I contact Synovis Life Technologies?

Synovis Life Technologies' mailing address is 2575 University Ave W, SAINT PAUL, MN 55114-1024, United States. The medical device company can be reached via phone at +1-651-7967300.


MarketBeat Community Rating for Synovis Life Technologies (NASDAQ SYNO)

Community Ranking:  2.0 out of 5 (star star)
Outperform Votes:  54 (Vote Outperform)
Underperform Votes:  78 (Vote Underperform)
Total Votes:  132
MarketBeat's community ratings are surveys of what our community members think about Synovis Life Technologies and other stocks. Vote "Outperform" if you believe SYNO will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SYNO will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 12/9/2018 by MarketBeat.com Staff

Featured Article: S&P 500 Index

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel